These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 29297004

  • 1. Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population.
    Mortensen MB, Nordestgaard BG.
    Ann Intern Med; 2018 Jan 16; 168(2):85-92. PubMed ID: 29297004
    [Abstract] [Full Text] [Related]

  • 2. Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat.
    Mortensen MB, Nordestgaard BG.
    JAMA Cardiol; 2019 Nov 01; 4(11):1131-1138. PubMed ID: 31577339
    [Abstract] [Full Text] [Related]

  • 3. ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.
    Mortensen MB, Nordestgaard BG, Afzal S, Falk E.
    Eur Heart J; 2017 Feb 21; 38(8):586-594. PubMed ID: 28363217
    [Abstract] [Full Text] [Related]

  • 4. Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines.
    Mortensen MB, Tybjærg-Hansen A, Nordestgaard BG.
    JAMA Cardiol; 2022 Aug 01; 7(8):836-843. PubMed ID: 35793078
    [Abstract] [Full Text] [Related]

  • 5. Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy.
    Mortensen MB, Afzal S, Nordestgaard BG, Falk E.
    J Am Coll Cardiol; 2015 Dec 22; 66(24):2699-2709. PubMed ID: 26700832
    [Abstract] [Full Text] [Related]

  • 6. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.
    Pavlovic J, Greenland P, Deckers JW, Brugts JJ, Kavousi M, Dhana K, Ikram MA, Hofman A, Stricker BH, Franco OH, Leening MJ.
    JAMA Cardiol; 2016 Sep 01; 1(6):708-13. PubMed ID: 27439175
    [Abstract] [Full Text] [Related]

  • 7. Guidelines versus trial-evidence for statin use in primary prevention: The Copenhagen General Population Study.
    Mortensen MB, Nordestgaard BG.
    Atherosclerosis; 2022 Jan 01; 341():20-26. PubMed ID: 34959205
    [Abstract] [Full Text] [Related]

  • 8. Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study.
    Shah RV, Spahillari A, Mwasongwe S, Carr JJ, Terry JG, Mentz RJ, Addison D, Hoffmann U, Reis J, Freedman JE, Lima JAC, Correa A, Murthy VL.
    JAMA Cardiol; 2017 Jun 01; 2(6):644-652. PubMed ID: 28315622
    [Abstract] [Full Text] [Related]

  • 9. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
    Kavousi M, Leening MJ, Nanchen D, Greenland P, Graham IM, Steyerberg EW, Ikram MA, Stricker BH, Hofman A, Franco OH.
    JAMA; 2014 Apr 09; 311(14):1416-23. PubMed ID: 24681960
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease.
    Delabays B, de La Harpe R, Vollenweider P, Fournier S, Müller O, Strambo D, Graham I, Visseren FLJ, Nanchen D, Marques-Vidal P, Vaucher J.
    Eur J Prev Cardiol; 2023 Nov 30; 30(17):1856-1864. PubMed ID: 37290056
    [Abstract] [Full Text] [Related]

  • 11. Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Miedema MD, Dardari ZA, Kianoush S, Virani SS, Yeboah J, Knickelbine T, Sandfort V, Rodriguez CJ, Nasir K, Blaha MJ.
    J Am Heart Assoc; 2018 Jun 13; 7(12):. PubMed ID: 29899017
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hyperlipidemia: Drugs for Cardiovascular Risk Reduction in Adults.
    Last AR, Ference JD, Menzel ER.
    Am Fam Physician; 2017 Jan 15; 95(2):78-87. PubMed ID: 28084704
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines.
    Pagidipati NJ, Navar AM, Mulder H, Sniderman AD, Peterson ED, Pencina MJ.
    JAMA; 2017 Apr 18; 317(15):1563-1567. PubMed ID: 28418481
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 2019 vs. 2016 ESC/EAS statin guidelines for primary prevention of atherosclerotic cardiovascular disease.
    Mortensen MB, Nordestgaard BG.
    Eur Heart J; 2020 Aug 14; 41(31):3005-3015. PubMed ID: 32227172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.